Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Remus Pharmaceuticals Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

3 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

948.95

100

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

100

Option Chain

Analyzes market sentiment, predicts Remus Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Remus Pharmaceutic - Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter

    14 Jul 2025, 3:11PM Remus Pharmaceuticals Limited has informed regarding Non-Applicability of the Regulation 27(2) of the SEBI (Listing Obligations and Disclosure Require
  • Remus Pharmaceutic - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    14 Jul 2025, 3:01PM Remus Pharmaceuticals Limited has informed the Exchange submission of Reconciliation of Share Capital Audit Report for the quarter ended June 30, 2025
  • Remus Pharmaceutic has submitted to BSE the Shareholding Pattern for the Period Ended July 07, 2025

    12 Jul 2025, 7:02AM As of July 2025, 70.85% is owned by Indian Promoters and 29.15% by Public. <p align=justify> Top five Promoters holding highest number of shares of Re
  • Remus Pharmaceutic - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    11 Jul 2025, 6:50PM Remus Pharmaceuticals Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations,
  • Remus Pharmaceutic - Alteration Of Capital and Fund Raising-XBRL

    7 Jul 2025, 12:15PM REMUS Pharmaceuticals Limited has informed the Exchange regarding Allotment of Securities
  • Remus Pharmaceutic - Allotment of Securities

    7 Jul 2025, 11:13AM Remus Pharmaceuticals Limited has informed the Exchange regarding allotment of 5892000 securities pursuant to Bonus at its meeting held on July 07, 20
  • Remus Pharmaceutic - Outcome of Board Meeting

    7 Jul 2025, 11:09AM Remus Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on July 07, 2025 -Allotment of Bonus Equity Shares
  • Remus Pharmaceutic - Disclosure under SEBI Takeover Regulations

    25 Jun 2025, 7:50PM Remus Pharmaceuticals Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India
  • Remus Pharmaceutic - Record Date

    24 Jun 2025, 2:33PM Remus Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Bonus is 04-Jul-2025.
  • Remus Pharmaceutic - Shareholders meeting

    23 Jun 2025, 7:35PM Remus Pharmaceuticals Limited has informed the Exchange regarding voting results of Postal Ballot
  • Remus Pharmaceutic - Shareholders meeting

    23 Jun 2025, 7:26PM Remus Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot
  • Remus Pharmaceutic - Incorporation-XBRL

    20 Jun 2025, 3:50PM REMUS PHARMACEUTICALS LIMITED has informed the Exchange regarding Incorporation
  • Remus Pharmaceutic - General Updates

    20 Jun 2025, 11:50AM Remus Pharmaceuticals Limited has informed the Exchange about incorporation of a new subsidiary company.
  • Remus Pharmaceutic - Outcome of Board Meeting

    20 Jun 2025, 11:43AM Remus Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on June 20, 2025.
  • Remus Pharmaceutic - Analysts/Institutional Investor Meet/Con. Call Updates

    23 May 2025, 7:13PM Remus Pharmaceuticals Limited has informed the Exchange about Transcript of the Earnings Conference Call H2 and FY2024-25
  • Remus Pharmaceutic - Copy of Newspaper Publication

    22 May 2025, 12:14PM Remus Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication for Postal Ballot Notice and other related information
  • Remus Pharmaceutic - Notice Of Shareholders Meetings-XBRL

    21 May 2025, 6:57PM REMUS PHARMACEUTICALS LIMITED has informed the Exchange about Notice of Shareholders Meeting for Postal Ballot
  • Remus Pharmaceutic - Shareholders meeting

    21 May 2025, 6:42PM Remus Pharmaceuticals Limited has informed the Exchange regarding Notice of Postal Ballot dated May 17, 2025, along with the explanatory statement, se
  • Remus Pharmaceutic - Analysts/Institutional Investor Meet/Con. Call Updates

    19 May 2025, 6:47PM Remus Pharmaceuticals Limited has informed the Exchange about Link of Recording
  • Remus Pharmaceutic - Investor Presentation

    19 May 2025, 4:11PM Remus Pharmaceuticals Limited has informed the Exchange about Investor Presentation
  • Remus Pharmaceutic - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    19 May 2025, 10:34AM REMUS PHARMACEUTICALS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transf
  • Remus Pharmaceutic - Analysts/Institutional Investor Meet/Con. Call Updates

    14 May 2025, 6:06PM Remus Pharmaceuticals Limited has informed the Exchange about Schedule of meet
  • Remus Pharmaceutic - Board Meeting Intimation

    14 May 2025, 1:23PM REMUS PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 17-May-2025 to consider and approve the Yearly Audited Finan
  • Remus Pharmaceutic - Board Meeting Intimation

    12 May 2025, 2:40PM REMUS PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 17-May-2025 to consider and approve the Yearly Audited Finan
  • Remus Pharmaceutic - Structural Digital Database

    25 Apr 2025, 6:48PM Remus Pharmaceuticals Limited has informed the Exchange regarding Compliance Certificate pursuant to Securities and Exchange Board of India (Prohibiti

Key fundamentals

Evaluate the intrinsic value of Remus Pharmaceuticals Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 244.36 83.5026 27.0783 6.6235 3.325
Liabilities 244.36 83.5026 27.0783 6.6235 3.325
Equity 5.89 1.473 1.085 1 0.01
Gross Profit 25.98 20.0439 10.5464 4.0707 0.7618
Net Profit 19.9 16.8197 8.5028 3.3857 1.0258
Cash From Operating Activities 15.59 2.4263 5.3129 5.0378 2.8379
NPM(%) 25.13 26.48 18.88 13.69 5.56
Revenue 79.16 63.4965 45.0273 24.7171 18.4181
Expenses 53.18 43.4526 34.4809 20.6464 17.6563
ROE(%) 7.77 6.57 3.32 1.32 0.4

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
02 May 2024 4 40 0 6911.75
27 Oct 2023 2 20 0 5537.5

Peers

Other companies within the same industry or sector that are comparable to Remus Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 933.30 0.89 30.97 0.00 301.39 0.54
Lotus Eye Hospital and Institute Ltd 75.41 1.51 215.46 0.00 3.55 0.00
Vaishali Pharma Ltd 12.77 -1.69 212.83 0.00 3.13 0.00
Astec Lifesciences Ltd 901.45 -0.84 0.00 0.00 -601.21 0.00

Company Info

The Company was originally incorporated as `Remus Pharmaceuticals Private Limited' as a private limited company, under the provisions of the Companies Act, 2013 vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat. Later on, pursuant to a special resolution passed by the shareholders in the Extra-Ordinary General Meeting held on January 02, 2023, the Company was converted from a private limited company to public limited company and consequently, the name of the Company was changed to "Remus Pharmaceuticals Limited", and a fresh certificate of incorporation dated January 06, 2023 was issued to the Company by the Registrar of Companies, Ahmedabad. The Corporate Identification Number of the Company is U24232GJ2015PLC084536. MAJOR EVENTS : 2015 - The Company was incorporated as a private limited company under the name "Remus Pharmaceuticals Private Ltd - Conversion of the company from Private Limited to Public Limited Company - Initiation of finished formulation exports and marketing 2019 -Collaboration & partnership with multinational pharmaceuticals 2022 -Initiation of strategic presence in a few key markets 2024 -The Company has issued Bonus Shares in the Ratio of 3:1.

The Company was originally incorporated as `Remus Pharmaceuticals Private Limited' as a private limited company, under the provisions of the Companies Act, 2013 vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat. Later on, pursuant to a special resolution passed by the shareholders in the Extra-Ordinary General Meeting held on January 02, 2023, the Company was converted from a private limited company to public limited company and consequently, the name of the Company was changed to "Remus Pharmaceuticals Limited", and a fresh certificate of incorporation dated January 06, 2023 was issued to the Company by the Registrar of Companies, Ahmedabad. The Corporate Identification Number of the Company is U24232GJ2015PLC084536. MAJOR EVENTS : 2015 - The Company was incorporated as a private limited company under the name "Remus Pharmaceuticals Private Ltd - Conversion of the company from Private Limited to Public Limited Company - Initiation of finished formulation exports and marketing 2019 -Collaboration & partnership with multinational pharmaceuticals 2022 -Initiation of strategic presence in a few key markets 2024 -The Company has issued Bonus Shares in the Ratio of 3:1.

Read More

Parent Organisation

Remus Pharmaceuticals Ltd.

Founded

21/09/2015

Managing Director

Mr.Arpit Deepakkumar Shah

NSE Symbol

REMUSSM

FAQ

The current price of Remus Pharmaceuticals Ltd is

The 52-week high for Remus Pharmaceuticals Ltd is

The market capitalization of Remus Pharmaceuticals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Remus Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Remus Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Remus Pharmaceuticals Ltd shares.

The CEO of Remus Pharmaceuticals Ltd is Mr.Arpit Deepakkumar Shah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT